Related Experiment Video
Updated: Jan 19, 2026

Evaluation of a Point-of-Care Testing Analyzer for Measuring Peripheral Blood Leukocytes
Published on: March 22, 2022
Variation between Point-of-care and Laboratory HbA1c testing in Clinical Practice
Shawn E Fellows1, Gabriela C Cipriano2
1Assistant Professor, Department of Pharmacy Practice Wegmans School of Pharmacy at St. John Fisher College, Rochester, NY.
Insights
Point-of-care hemoglobin A1c (HbA1c) testing may show disparities compared to laboratory results. Rely on self-monitoring and symptoms, not just POCT HbA1c, for diabetes diagnosis and therapy guidance.
Area of Science:
- Clinical Chemistry
- Point-of-Care Testing
- Diabetes Diagnostics
Background:
- Hemoglobin A1c (HbA1c) is crucial for diabetes management.
- Point-of-care testing (POCT) offers rapid results but requires validation against laboratory standards.
- Federally Qualified Health Centers (FQHCs) often utilize POCT for accessibility.
Purpose of the Study:
- To investigate discrepancies between POCT and laboratory HbA1c measurements.
- To assess the reliability of POCT HbA1c reporting within an FQHC setting.
Main Methods:
- Retrospective review of electronic medical records at an FQHC.
- Comparison of same-day POCT HbA1c and centralized laboratory venous HbA1c results.
- Manual data extraction to identify potential confounding variables.
Main Results:
- Analysis of 42 samples from 40 patients revealed a median HbA1c difference of 1.5 mmol/mol (0.15%).
- Observed HbA1c differences ranged significantly, from -26 to 52 mmol/mol (-2.4% to 4.8%).
- Two patients with comorbidities showed potential impact on POCT HbA1c accuracy.
Conclusions:
- POCT HbA1c should not be used as the sole method for diagnosing pre-diabetes and diabetes.
- Clinical decisions based on HbA1c require correlation with self-monitoring of blood glucose and patient symptoms (hypo- and hyperglycemia).
Objective:
The aim of this study was to identify potential disparities between point-of-care testing (POCT) and laboratory hemoglobin A1c (HbA1c) reporting at a Federally Qualified Health Center (FQHC).
Methods:
The electronic medical record was reviewed to identify POCT HbA1c done at a FQHC and centralized laboratory venous HbA1c performed on the same day. Manual data extraction was used to identify potential variables that could account for disparities between POCT and laboratory testing.
Results:
A total of 42 samples in 40 patients were identified. The median HbA1c difference was 1.5 mmol/mol (0.15%) and ranged from -26 to 52 mmol/mol (-2.4 to 4.8%). Of the patients in the study, two had underlying comorbidities that could affect the POCT HbA1c.
Conclusion:
Point-of-care HbA1c testing should not be used in solidarity to diagnosis pre-diabetes and diabetes. When using HbA1c results to guide therapy, self-monitoring of blood glucose and symptoms of both hypo- and hyperglycemia should be correlated to help determine appropriate therapy.
Related Concept Videos
Variability: Analysis
The range is a simple measure of variability, indicating the difference between the highest and...
Errors occurring during blood pressure monitoring
Several factors...
Testing a Claim about Standard Deviation
The hypothesis testing for the claim of population standard deviation (or variance) requires the data and samples to be random and unbiased. The population distribution also must be normal. There is no specific requirement on the sample size as the estimation is based on the chi-square distribution.
As a first step, the hypothesis (null and alternative) concerning the claim about...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
Accuracy and Errors in Hypothesis Testing
In hypothesis testing, the probability of making a Type I error, denoted as α, is commonly set at 0.05. This significance level indicates a 5%...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...

